PURE Bioscience, Inc.
PURE
$0.0675
$0.006711.02%
OTC PK
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -580.00K | -798.00K | -689.00K | -756.00K | -857.00K |
| Total Depreciation and Amortization | 1.00K | 1.00K | -- | 38.00K | 36.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.00K | 27.00K | 57.00K | 38.00K | 92.00K |
| Change in Net Operating Assets | 34.00K | 226.00K | 129.00K | 87.00K | 114.00K |
| Cash from Operations | -512.00K | -544.00K | -503.00K | -593.00K | -615.00K |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 850.00K | 400.00K | 500.00K | 500.00K | 500.00K |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 850.00K | 400.00K | 500.00K | 500.00K | 500.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 338.00K | -144.00K | -3.00K | -93.00K | -115.00K |